Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lanxess AG
XETRA:LXS
|
DE |
Bharat Immunologicals and Biologicals Corporation Ltd
Net Income
Bharat Immunologicals and Biologicals Corporation Ltd
Net Income Peer Comparison
Bharat Immunologicals and Biologicals Corporation Ltd
Glance View
Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacture and market of pharmaceutical products. The company is headquartered in Bulandshahr, Uttar Pradesh. The firm is primarily engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarrhea management Kit and BIB Sweet Tablets. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into Plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.
See Also
What is Bharat Immunologicals and Biologicals Corporation Ltd's Net Income?
Net Income
-184.8m
INR
Based on the financial report for Sep 30, 2023, Bharat Immunologicals and Biologicals Corporation Ltd's Net Income amounts to -184.8m INR.
What is Bharat Immunologicals and Biologicals Corporation Ltd's Net Income growth rate?
Net Income CAGR 5Y
-32%
Over the last year, the Net Income growth was -97%. The average annual Net Income growth rates for Bharat Immunologicals and Biologicals Corporation Ltd have been -79% over the past three years , -32% over the past five years .
